skip to Main Content

KRAS Gene May Drive Immune ‘Evasion’ In Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
A new study in Nature Communications takes an initial step toward better understanding how KRAS drives immune evasion and demonstrates a lowering of the KRAS activity resulting in a more favorable immune environment to fight cancer.

Previous strategies to block the KRAS oncogene therapeutically have focused on counteracting its growth-promoting role in cancer. Read more . . . 

 


Back To Top